Lotus Eye Hospital's governance record shows repeated compliance failures, including a SEBI insider-trading penalty and a heavily pledged promoter holding, while its financial statements carry clean audit opinions despite an incomplete fixed-asset register and unresolved tax disputes.
Key findings
- Promoter governance shows repeated compliance failures
Critical- A promoter executed a contra trade of 2,07,000 shares worth Rs. 1,75,85,080 on 28-29 November 2023, drawing a Rs. 10,00,000 SEBI penalty paid on 29-12-2023. Promoter pledge stood at 87.15% of holdings, up from 0.00% a year earlier. The Managing Director's remuneration rose from Rs. 3,50,000 to Rs. 6,00,000 per month effective 10 August 2026, while PAT fell from Rs. 4.08 crore in FY23 to Rs. 0.15 crore in the latest period. Independent director meetings and evaluations were not conducted during FY2023-24. - Recurring SEBI/stock-exchange compliance failures span six years
Critical- BSE and NSE imposed fines totalling Rs. 10,24,240 for non-compliance with Regulation 17(1A) of SEBI (LODR), with communications dated 28.11.2025, 27.02.2026 and 27.05.2026. The company imposed a Rs. 10,00,000 penalty on designated person S Rajkumar and remitted it to SEBI-IPEF on 29-12-2023. In FY2021-22, the company failed to file Corporate Governance Reports on time, and in FY2019-20 it missed related-party disclosure deadlines and dematerialisation requirements. - Seven straight years of clean audit opinions sit alongside an incomplete fixed-asset register
Major- The statutory auditor issued an unqualified opinion for FY2026, dated May 26, 2026. However, CARO clause (i)(b) states the auditor was "unable to comment on discrepancies due to incomplete fixed asset register". This same issue has persisted since at least FY2020. The FY2023 report also noted the audit trail "was not enabled at the database level for the entire year". - Contingent tax and consumer disputes persist across years
Major- Contingent liabilities from tax authorities stood at Rs. 82.17 Lakhs as at March 31, 2025. An income-tax order of Rs. 55.27 Lakhs for FY 2016-17 is under appeal, and a Kerala sales tax demand of Rs. 26.77 Lakhs is pending before appellate authorities. A customer complaint seeks Rs. 17.06 Lakhs in compensation, and no provisions have been made for any disputed amounts. - Operating cash flow consistently exceeds modest PAT, but capital allocation is constrained
Minor- CFO exceeded PAT in each of FY22 through FY26, with CFO/PAT of 1.48x in FY22 and 37.75x in FY26. Free cash flow was negative at ₹-9.92 crore in FY26 and ₹-2.09 crore in FY25. ROCE declined from 6.79% in FY24 to 1.06% in FY26, and no dividend was recommended for FY ended 31.03.2025. - Revenue recognition is routine, but receivables quality shows small, recurring credit losses
Minor- Revenue recognition for hospital services was flagged as a Key Audit Matter in FY2022-23, with no material misstatement identified. Trade receivables written off during FY2024-25 amounted to Rs. 1.40 lakhs. Receivable days remained low at 8.21 days in FY2025-26, down from 9.74 days in FY2024-25.
What to watch
- Shareholder votes on remuneration. The FY2025-26 Annual Report notice proposes that the AGM on September 23, 2026, approve revising Ms. Sangeetha Sundaramoorthy's monthly remuneration from Rs. 3,50,000 to Rs. 6,00,000 effective August 10, 2026.
- SEBI action on director designation. SEBI may act on the company's position that changing a Whole-time Director to Non-Executive Director does not require approval under Regulation 17(1A), as stated in the Postal Ballot Notice dated 18th Dec 2025.
- Fixed-asset register completion. As of the FY2025-26 annual report dated May 26, 2026, the company is in the process of updating its fixed-asset register, and the auditor remains unable to comment on discrepancies due to its incomplete status.
- Audit trail at database level. The FY2023 annual report noted the audit trail "was not enabled at the database level for the entire year".
Bottom line: This is a disclosed and audited record with clean opinions and cash flow that consistently covers profit. The risk sits in governance: a promoter with 87% of holdings pledged, repeated regulatory fines, and an auditor unable to verify fixed assets for six years. The current AGM notice proposes a revision to the Managing Director's remuneration, and the fixed-asset register update is in the process.